Disclosing Individual Results in Dementia Research: A Proposed Study Participant’s Bill of Rights

This Study Participant’s Bill of Rights is a call to action for researchers in Alzheimer’s disease and related dementias (ADRD) to proactively design clinical studies that provide the option for research participants to learn their individual research results if they choose, and in a manner that ens...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Alzheimer's disease 2022-01, Vol.90 (3), p.945-952
Main Authors: Walter, Sarah, Taylor, Angela, Tyrone, Jamie, Langer, Sara, Pagan, John-Richard, Hummel, Cynthia Huling, Wheaton, Bonnie M., Zallen, Doris T., Rosen, Allyson C.
Format: Article
Language:English
Subjects:
Alzheimer Disease
Alzheimer's disease
Clinical trials
Dementia
Dementia disorders
Disclosure
Humans
Neurodegenerative diseases
Regional development
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This Study Participant’s Bill of Rights is a call to action for researchers in Alzheimer’s disease and related dementias (ADRD) to proactively design clinical studies that provide the option for research participants to learn their individual research results if they choose, and in a manner that ensures study integrity. This Bill of Rights was crafted by a committee of study participants, care partners, representatives of dementia advocacy organizations, and other stakeholders in dementia research for the Advisory Group on Risk Education for Dementia (AGREEDementia). The framework developed by the Multi-Regional Clinical Trials (MRCT) Return of Individual Research Results provides a useful context for researchers to plan their studies and disclosure.
ISSN:1387-2877
1875-8908
DOI:10.3233/JAD-220810